Aquestive Therapeutics, Inc. (AQST)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$4.07
-0.85%
Mkt Cap $405.17M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | $13.29M | $13.02M | -2.04% | -$0.13 | -$0.26 | -100.00% | — | — |
| Q4 2025 Nov 5, 2025 | $12.94M | $12.81M | -1.05% | -$0.11 | -$0.14 | -27.27% | — | — |
| Q3 2025 Aug 11, 2025 | $12.20M | $10.00M | -17.98% | -$0.18 | -$0.14 | +22.22% | — | — |
| Q2 2025 May 12, 2025 | $12.23M | $8.72M | -28.70% | -$0.17 | -$0.24 | -41.18% | — | — |
| Q1 2025 Mar 5, 2025 | $13.11M | $11.87M | -9.50% | -$0.14 | -$0.19 | -35.71% | — | — |
| Q4 2024 Nov 4, 2024 | $13.13M | $13.54M | +3.17% | -$0.12 | -$0.13 | -8.33% | — | — |
| Q3 2024 Aug 6, 2024 | $12.38M | $20.10M | +62.35% | -$0.11 | -$0.03 | +72.73% | — | — |
| Q2 2024 May 7, 2024 | $12.26M | $12.05M | -1.69% | -$0.09 | -$0.17 | -88.89% | — | — |
| Q1 2024 Mar 5, 2024 | $11.63M | $13.21M | +13.55% | -$0.08 | -$0.12 | -50.00% | — | — |
| Q4 2023 Nov 6, 2023 | $11.63M | $13.00M | +11.80% | -$0.11 | -$0.03 | +72.73% | — | — |
| Q3 2023 Aug 7, 2023 | $11.01M | $13.24M | +20.26% | -$0.11 | -$0.10 | +9.09% | — | — |
| Q2 2023 May 2, 2023 | $9.92M | $11.13M | +12.24% | -$0.10 | $0.11 | +210.00% | — | — |
| Q1 2023 Mar 7, 2023 | $10.42M | $10.68M | +2.51% | -$0.21 | -$0.23 | -9.52% | — | — |
| Q4 2022 Nov 1, 2022 | $11.00M | $11.46M | +4.19% | -$0.30 | -$0.23 | +23.33% | — | — |
| Q3 2022 Aug 2, 2022 | $10.57M | $13.27M | +25.47% | -$0.41 | -$0.36 | +12.20% | — | — |
| Q2 2022 May 3, 2022 | $10.13M | $12.27M | +21.13% | -$0.45 | -$0.32 | +28.89% | — | — |
| Q1 2022 Mar 8, 2022 | $9.36M | $11.08M | +18.33% | -$0.37 | -$0.38 | -2.70% | — | — |
| Q4 2021 Nov 2, 2021 | $11.01M | $13.29M | +20.68% | -$0.40 | -$0.37 | +7.50% | — | — |
| Q3 2021 Aug 3, 2021 | $15.35M | $15.35M | +0.00% | -$0.42 | -$0.33 | +21.43% | — | — |
| Q2 2021 May 4, 2021 | $6.24M | $11.12M | +78.24% | -$0.44 | -$0.41 | +6.82% | — | — |